Research programme: secretory diarrhoea therapy - Icagen
Latest Information Update: 11 Feb 2008
At a glance
- Originator Icagen
- Class Small molecules
- Mechanism of Action Ion channel modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Diarrhoea
Most Recent Events
- 16 Aug 2001 No-Development-Reported for Diarrhoea in USA (Unknown route)
- 07 Dec 1998 New profile
- 07 Dec 1998 Preclinical development for Diarrhoea in USA (Unknown route)